Martin Hauer‐Jensen

High Impact

Retired

University of Arkansas for Medical Sciences

faculty

65 h-index 337 pubs 17,576 cited

Research Areas

Radioprotective Agents Radiation Injury Models Phytochemicals and Antioxidant Activities Epigenetics and DNA Methylation Cancer Treatment and Pharmacology Immune Cell Function and Interaction Genomics and Phylogenetic Studies

Links

ORCID Google Scholar Lab Website

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Martin Hauer‐Jensen's research has focused on the effects of gamma-tocotrienol as a radioprotective agent in nonhuman primate models of acute radiation syndrome, investigating its impact on intestinal and hematopoietic injury. His work also includes studies on dietary methionine deficiency and genetic instability in immune cells, as well as cytogenetic and epigenetic aberrations in human populations exposed to radiation. Hauer‐Jensen has also been involved in clinical trials examining the long-term effects of radiotherapy for pelvic cancer.

Metrics

h-index: 65
Publications: 337
Citations: 17,576

Selected Publications

Serum Proteomic Signatures in Nonhuman Primates after Treatment with a Radiation Countermeasure and Exposure to a Partial- or Total-body Supralethal Radiation Dose (2025) DOI
Exposure to a Single Dose of Space-Relevant Proton Radiation Alters the Intestinal One-Carbon Metabolism Pathway and Microbiome in Mice (2025) DOI
Serum Metabolomic Signatures in Nonhuman Primates Treated with a Countermeasure and Exposed to Partial- or Total-Body Radiation (2025) DOI
Pathology of acute sub-lethal or near-lethal irradiation of nonhuman primates prophylaxed with the nutraceutical, gamma tocotrienol (2024) DOI
Don't CUT: Respecting the Potency of Radiation (2024) DOI
Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol (2024) DOI
Modulation of Hematopoietic Injury by a Promising Radioprotector, Gamma-Tocotrienol, in Rhesus Macaques Exposed to Partial-Body Radiation (2023) DOI
Gamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model (2022) DOI
Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model (2022) DOI
Cytogenetic and epigenetic aberrations in peripheral lymphocytes of northwest Arkansas Marshallese (2022) DOI
Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate (2022) DOI
Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study (2022) DOI
Methods for induction and assessment of intestinal permeability in rodent models of radiation injury (2022) DOI
Plasma Metabolomics in a Nonhuman Primate Model of Abdominal Radiation Exposure (2021) DOI
Dietary Methionine Deficiency Enhances Genetic Instability in Murine Immune Cells (2021) DOI